Hologic, Inc.  

(Public, NASDAQ:HOLX)   Watch this stock  
Find more results for HOLX
43.46
-0.39 (-0.89%)
Jan 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 42.55 - 43.57
52 week 35.76 - 46.80
Open 43.20
Vol / Avg. 4.36M/2.44M
Mkt cap 11.87B
P/E 16.44
Div/yield     -
EPS 2.64
Shares 275.68M
Beta 0.95
Inst. own 103%
Mar 8, 2018
Hologic Inc Annual Shareholders Meeting (Estimated) - 8:00AM EST - Add to calendar
Feb 8, 2018
Q1 2018 Hologic Inc Earnings Call - 4:30PM EST - Add to calendar
Feb 8, 2018
Q1 2018 Hologic Inc Earnings Release - 4:00PM EST - Add to calendar
Jan 9, 2018
Hologic Inc at JPMorgan Healthcare Conference - Q&A Session
Jan 9, 2018
Hologic Inc at JPMorgan Healthcare Conference - Webcast
Nov 30, 2017
Hologic Inc at Deutsche Bank MedTools and Diagnostics One-on-One Day
Nov 29, 2017
Hologic Inc at Piper Jaffray Healthcare Conference - Webcast
Nov 14, 2017
Hologic Inc at Stifel Healthcare Conference - Webcast
Nov 8, 2017
Q4 2017 Hologic Inc Earnings Call - Webcast
Nov 8, 2017
Q4 2017 Hologic Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2017
Net profit margin 10.30% 24.70%
Operating margin 13.54% 44.69%
EBITD margin - 30.50%
Return on average assets 4.12% 9.88%
Return on average equity 11.74% 30.67%
Employees 6,233 -
CDP Score - -

Address

250 Campus Dr
MARLBOROUGH, MA 01752-3020
United States - Map
+1-508-2632900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Officers and directors

Stephen P. MacMillan Chairman of the Board, President, Chief Executive Officer
Age: 53
Bio & Compensation  - Reuters
Robert W. McMahon Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Sanjay Prabhakaran Regional President - Asia
Bio & Compensation  - Reuters
Peter J. Valenti III Division President- Breast and Skeletal Health
Age: 53
Bio & Compensation  - Reuters
Jan Verstreken Regional President - Europe,Middle EastandAfrica(EMEA) and Canada
Bio & Compensation  - Reuters
Thomas A. West Division President- Diagnostics
Age: 53
Bio & Compensation  - Reuters
Michael J. Watts Vice President, IR Contact Officer
Bio & Compensation  - Reuters
John M. Griffin General Counsel
Age: 56
Bio & Compensation  - Reuters
Elaine S. Ullian Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Charles J. Dockendorff Director
Age: 62
Bio & Compensation  - Reuters